On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.

On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.